Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding-Reference-Cited by-同舟云学术

Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding

Published:2017-09 Issue:9 Volume:28 Page:2321-2322
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Resteghini C.,Locati L.D.,Bossi P.,Bergamini C.,Guzzo M.,Licitra L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/9/2321/19709794/mdx251.pdf

Reference2 articles.

1. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer;Schlumberger;N Engl J Med,2015

2. Relationship between toxicities and clinical benefits of newly approved tyrosine kinase inhibitors in thyroid cancer: a meta-analysis of literature;Ye;J Can Res Ther,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TSH elevation in neonatal screening as the first manifestation of other associated diseases;Endocrinología, Diabetes y Nutrición (English ed.);2023-04

2. Severe intra-abdominal bleeding after lenvatinib use in patient with follicular Hürthle cell carcinoma;Endocrinología, Diabetes y Nutrición (English ed.);2023-04

3. Hemorragia grave intraabdominal tras el uso de lenvatinib en un paciente con carcinoma folicular de células de Hürthle;Endocrinología, Diabetes y Nutrición;2023-04

4. Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives;Hormone and Metabolic Research;2021-03

5. Invasive procedures in patients undergoing treatment with lenvatinib for thyroid cancer;Molecular and Clinical Oncology;2021-02-26